Actin (red) interacts with myosin, shown in globular form (pink) and a filament form (black line). The model shown is that of H. E. Huxley, modified to indicate bending (curved arrow) near the middle ...
Bristol Myers Squibb has secured FDA approval for mavacamten, for obstructive hypertrophic cardiomyopathy (obstructive HCM). The company gained the first-in-class cardiac myosin inhibitor through its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results